Elaine Huspeni

Experience

• 

  Stanford University

  Sept 2010 - Jul 2011

  Research Assistant

  Developed and optimized a protocol for E. coli expression of GST-tagged C1b subunit of Protein Kinase C for use in bryostatin-binding studies.

• 

  Solum, Inc.

  Aug 2011 - Aug 2013

  Aided in the setup, staffing, and training of personnele for the launch of Solum's brand new soil analysis lab in Ames, IA. Helped develop and deploy Quality Control process to ensure timely delivery of quality data to customers. Providing ongoing training and troubleshooting to reduce rerun rate and continue to improve data quality. Developed and implemented high-throughput testing methods to analyze soil pH, buffering capacity, moisture content, and organic material.

  • Quality Control Supervisor

    Jul 2012 - Aug 2013

  • Staff Scientist

    Aug 2011 - Jul 2012
• 

  Koch Ag & Energy Solutions, LLC

  May 2015 - Aug 2015

  Business Analyst Intern
• 

  Koch Ag & Energy Solutions, LLC

  Jan 2016 - Aug 2017

  • Prepared research for and participated in strategic analysis of Koch Agronomic Services business vision review. • Performed financial and strategic analysis and for investment opportunities ranging from $10-$25MM in value. • Provided deal support for sale process of Bunn Fertilizer Ltd. to Origin Enterprises, including data room and Q&A process management.• Researched and developed points-of-view on market trends to identify potential investment opportunities in areas such as value-added fertilizers, biological plant health products, and crop protection chemicals

  • Strategy & Business Development Associate

    Apr 2017 - Aug 2017

  • Sr. Analyst - Strategy & Business Development

    Jan 2016 - Apr 2017
• 

  AgTech Accelerator™

  Sept 2017 - Feb 2019

  Deal Principal

  • Performed financial and strategic analysis as part of diligence for agricultural venture investment opportunities. • Operationally engaged with portfolio companies to support and track progress against investment milestones. • Supported business development activities for portfolio companies, including Skyline Vet Pharma, as they reached key value inflection points, including CIM and data room support for partnership process for assets or full sale.

• 

  Skyline Vet Pharma

  Mar 2019 - Jul 2019

  Strategy & Business Development Director

  Provided deal support for licensing process, including CIM preparation, road show presentations, financial projections, and data room management.

• 

  Plant Response

  Sept 2019 - Mar 2020

  Finance, Strategy, and Operations Consultant

  Undertook diligence, transition, and integration activities for Joint Venture with Koch Biologicals and subsequent acquisition of Pathway Biologicals.

• 

  Fifth Third Bank

  Jul 2022 - now

  • Senior Data Scientist - AVP

    Oct 2024 - now

  • Data Scientist - AVP

    Jul 2022 - Oct 2024